Answers are grounded in this paper and cite their sources.
Synthesis and molecular docking of nitroimidazole-triazole hybrids shows strong antimicrobial effectiveness and binding affinities.
A series of nitroimidazole-triazole hybrids 7a-d and 10a-d have been synthesized through the Huisgen cycloaddition of 1-(2-azidoacetyl)-2-methyl-5-nitro-1 H -imidazole (3) with 2-((4-propargyloxy)benzylidene)malononitrile (4) or ethyl 2-cyano-3-((4-propargyloxy)phenyl) acrylate (8) , followed by cyclization of imidazole-triazole compounds (5 and 9) with N -aryl cyanoacetamides 6a-d . The DFT calculations for the synthesized nitroimidazole-based hybrids revealed comparable twisted configurations and similar Highest occupied molecular orbitals (HOMO)-lowest unoccupied molecular orbital (LUMO) constructions. Consequently, their energy gap ranged from 2.93 to 3.33 eV, where analogues 7b and 5 exhibited the utmost and least values, respectively. In addition, the antimicrobial effectiveness of the prepared nitroimidazole-based hybrids against Gram(+ve), Gram(-ve), and fungal strains were assessed using MIC and IZ assays. Imidazole-triazole hybrids 7a , 7b , and 10d displayed the highest activity, particularly against S. aureus , B. subtilis , and E. coli (minimum inhibitory concentrations (MIC) = 3.125-6.25 µg.mL -1 ), comparable to the reference antibiotics. However, nitroimidazole-triazole hybrid 9 demonstrated a robust fungicidal effect on C. albicans (MIC = 3.125 µg.mL -1 ), comparable to cycloheximide. The molecular docking study was performed to evaluate interactions of the manufactured series with the target protein (PDB: 1BDD). The hybrids 5 and 10d presented the maximum binding affinities (S = -7.1215 and -7.2123 kcal.mol -1 ). These findings suggest that nitroimidazole-hybrids, particularly 10d and 5 , represented promising scaffolds for further development due to their strong binding affinities and diverse interaction profiles. Furthermore, the Swiss Absorption, distribution, metabolism, and excretion (ADME) study provided an in-depth pharmacokinetic evaluation of the new nitroimidazole hybrids, a robust tool for predicting drug-likeness and bioavailability. Hybrids 5 and 9 exhibited favorable solubility with low molecular weights, while hybrids 7a-d and 10a-d showed moderate solubility but higher molecular weights and increased Lipinski violations. The bioavailability scores showed moderate to low, with nitroimidazole-hybrids 5 and 9 . These pharmacokinetic results offered valuable insights into the drug-likeness and potential therapeutic pertinency of these hybrids.
No takes yet. Share an insight, caveat, or question.
Aljowni et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: